Heritage Bio Labs
Research Library
Explore 411 articles about peptides, research compounds and related topics, with links to the original studies.
Find articles
Matching articles
Showing 49–60 of 124 articles · Check methods and identity
- Check methods and identity
How removing different numbers of residues changed a cell assay
IGF-1 DES 1,3 refers to des(1–3)IGF-1, a 67-residue form lacking the first three amino acids of full-length IGF-1. An older experiment tested whether the number of removed residues changed the effect on protein production in a cell model.
IGF-1 DES 1,31 source (1989)
- Check methods and identity
What a cultured ovarian-cell experiment measured about progesterone
IGF-1 DES 1,3 refers here to des(1–3)IGF-1, a 67-amino-acid form missing the first three residues of full-length IGF-1. Researchers used the shortened molecule to ask how locally produced binding proteins influence a hormone response in cultured ovarian cells.
IGF-1 DES 1,31 source (1992)
- Check methods and identity
How a liver-derived cell line helped test feedback on a binding protein
IGF-DES 1,3 is used here for des(1–3)IGF-1, a 67-residue analogue lacking the first three amino acids of mature IGF-1. An older experiment asked whether the shortened form changes the amount of an IGF-binding protein produced by a liver-derived cell line.
IGF-DES 1,31 source (1993)
- Check methods and identity
What an intestinal adaptation study measured after surgery in rats
IGF-DES 1,3 commonly refers to des(1–3)IGF-1, the shortened form of insulin-like growth factor 1 missing its first three residues. What did an older animal study find when it compared the truncated and full-length forms after intestinal surgery?
IGF-DES 1,32 sources (1989, 1992)
- Check methods and identity
Why protein measurements and glucose measurements diverged in a diabetes model
IGF-DES 1,3 refers here to des(1–3)IGF-1, the form missing the first three residues of mature insulin-like growth factor 1. An animal experiment asked how the shortened variant affected protein metabolism in rats with experimentally induced diabetes.
IGF-DES 1,32 sources (1989, 1991)
- Check methods and identity
What the IGF-2 LR3 Label Can Reliably Tell Us
The name IGF-2 LR3 does not identify a confirmed sequence in the supplied catalog. It combines wording associated with two distinct research subjects: human IGF-II and Long R3 IGF-I. Both are useful to study. Neither can be assigned to an unidentified material by similarity of name.
IGF-2 LR32 sources (1992, 2026)
- Check methods and identity
What a 2026 Placenta Study Measured About IGF2 and Birth Weight
The label IGF-2 LR3 has not been matched to a defined material here. A study of native IGF2 in human tissue helps explain the biology of a related name, without establishing effects of that label.
IGF-2 LR31 source (2026)
- Check methods and identity
What Studies of Defined IGF-II Variants Teach About Unclear Labels
The catalog name IGF-2 LR3 is not enough to identify a verified variant. There are published experiments with other, explicitly named IGF-II variants. They are useful examples of how changing a known molecule can change its behavior, not substitutes for research on the unclear label.
IGF-2 LR31 source (2025)
- Check methods and identity
What yeast production and a cell proliferation assay can establish
IGF-LR3 is an 83-residue relative of human insulin-like growth factor 1 with an extension and an arginine substitution. One research question is how investigators test whether a recombinant preparation retains biological activity.
IGF-LR32 sources (1992, 2023)
- Check methods and identity
What a placebo-controlled trial measured after bowel resection
Ipamorelin is a synthetic five-residue agonist of the ghrelin receptor. A randomized trial asked whether it could help adults recover coordinated bowel function after part of the intestine was removed. No recent primary clinical trial replacing the older evidence for this question was identified.
Ipamorelin2 sources (2014, 2024)
- Check methods and identity
How the original ipamorelin study tested receptor selectivity
Ipamorelin is a synthetic five-residue peptide developed as a growth hormone secretagogue. Its original laboratory and animal experiments asked whether it would stimulate growth hormone release through the same receptor system as other secretagogues.
Ipamorelin2 sources (1998, 2024)
- Check methods and identity
What the Four Ingredient KLOW Label Can Reliably Tell Us
KLOW is a catalog name for a mixture, rather than the name of one defined peptide. The formulation described in the supplied catalog names BPC-157, TB-500, KPV and GHK-Cu. That list describes the intended ingredients.
KLOW Blend4 sources (2026)
Browse by product
- A4 Amyloid Beta6 articles
- ACE-0316 articles
- ACE-0836 articles
- Adipotide6 articles
- AICAR6 articles
- AOD-96046 articles
- ARA-2906 articles
- BPC-1576 articles
- BPC-157 / TB-5006 articles
- Cagrilintide7 articles
- CJC-1295 (No DAC) / GHRP-26 articles
- CJC-1295 (No DAC) / GHRP-66 articles
- CJC-1295 (No DAC) / Ipamorelin6 articles
- CJC-1295 No DAC6 articles
- CJC-1295 With DAC6 articles
- DSIP6 articles
- Epitalon6 articles
- Follistatin 3156 articles
- Follistatin 3446 articles
- Fragment 176-1916 articles
- GHK-Cu6 articles
- GHRP-26 articles
- GHRP-66 articles
- GLOW 2 Blend6 articles
- GLOW Blend6 articles
- GLP-1 SEMA6 articles
- GLP-2 TIRZ6 articles
- Glutathione6 articles
- HCG6 articles
- Hexarelin6 articles
- Human Relaxin-26 articles
- IGF-1 DES 1,36 articles
- IGF-1 Human6 articles
- IGF-2 LR36 articles
- IGF-DES 1,36 articles
- IGF-LR36 articles
- Ipamorelin6 articles
- Kisspeptin-106 articles
- KLOW Blend6 articles
- KPV6 articles
- Lipopeptide6 articles
- Liraglutide6 articles
- Melanotan II5 articles
- MGF6 articles
- MOTS-C6 articles
- MSC Exosomes6 articles
- Myostatin6 articles
- Myostatin HMP (GDF8)6 articles
- Oxytocin7 articles
- PEG-MGF6 articles
- Pinealon6 articles
- PT-1416 articles
- RETA / IGF-1 LR36 articles
- RETA GLP-36 articles
- Selank6 articles
- SEMA / IGF-1 LR36 articles
- Semax6 articles
- Sermorelin6 articles
- SLU-PP-3326 articles
- SNAP-86 articles
- Survodutide7 articles
- TB-5006 articles
- Tesamorelin6 articles
- Thymosin Alpha-16 articles
- TIRZ / IGF-1 LR36 articles
- TIRZ GLP-26 articles
- Trevogrumab6 articles
- Triptorelin GnRH6 articles
